Annual EBIT
-$28.88 M
-$237.00 K-0.83%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual earnings before interest & taxes is -$28.88 million, with the most recent change of -$237.00 thousand (-0.83%) on December 31, 2023.
- During the last 3 years, APVO annual EBIT has fallen by -$1.38 million (-5.03%).
- APVO annual EBIT is now -34.94% below its all-time high of -$21.40 million, reached on December 31, 2021.
Performance
APVO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.21 M
+$811.00 K+13.46%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly earnings before interest & taxes is -$5.21 million, with the most recent change of +$811.00 thousand (+13.46%) on September 30, 2024.
- Over the past year, APVO quarterly EBIT has increased by +$1.17 million (+18.34%).
- APVO quarterly EBIT is now -29.03% below its all-time high of -$4.04 million, reached on December 31, 2021.
Performance
APVO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$24.60 M
+$1.35 M+5.19%
September 30, 2024
Summary
- As of February 8, 2025, APVO TTM earnings before interest & taxes is -$24.60 million, with the most recent change of +$1.35 million (+5.19%) on September 30, 2024.
- Over the past year, APVO TTM EBIT has increased by +$4.28 million (+14.80%).
- APVO TTM EBIT is now -121.62% below its all-time high of -$11.10 million, reached on March 31, 2015.
Performance
APVO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APVO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | +18.3% | +14.8% |
| 3 y3 years | -5.0% | +18.3% | +14.8% |
| 5 y5 years | +44.1% | +34.3% | +39.9% |
APVO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.9% | at low | -29.0% | +36.3% | -22.3% | +21.6% |
| 5 y | 5-year | -34.9% | +29.5% | -29.0% | +36.3% | -22.3% | +39.9% |
| alltime | all time | -34.9% | +57.4% | -29.0% | +73.3% | -121.6% | +61.5% |
Aptevo Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.21 M(-13.5%) | -$24.60 M(-5.2%) |
| Jun 2024 | - | -$6.02 M(-13.7%) | -$25.95 M(-7.7%) |
| Mar 2024 | - | -$6.98 M(+9.4%) | -$28.11 M(-2.7%) |
| Dec 2023 | -$28.88 M(+0.8%) | -$6.38 M(-2.7%) | -$28.88 M(-4.3%) |
| Sep 2023 | - | -$6.56 M(-19.8%) | -$30.18 M(-3.9%) |
| Jun 2023 | - | -$8.18 M(+5.4%) | -$31.40 M(+2.0%) |
| Mar 2023 | - | -$7.76 M(+0.9%) | -$30.79 M(+7.5%) |
| Dec 2022 | -$28.64 M(+33.8%) | -$7.68 M(-1.3%) | -$28.64 M(+14.6%) |
| Sep 2022 | - | -$7.78 M(+2.9%) | -$25.00 M(+13.8%) |
| Jun 2022 | - | -$7.56 M(+34.8%) | -$21.96 M(+9.1%) |
| Mar 2022 | - | -$5.61 M(+38.9%) | -$20.12 M(-6.0%) |
| Dec 2021 | -$21.40 M(-22.2%) | -$4.04 M(-14.9%) | -$21.40 M(-11.5%) |
| Sep 2021 | - | -$4.75 M(-17.0%) | -$24.18 M(-5.8%) |
| Jun 2021 | - | -$5.72 M(-16.9%) | -$25.68 M(-4.1%) |
| Mar 2021 | - | -$6.89 M(+1.0%) | -$26.76 M(-2.7%) |
| Dec 2020 | -$27.49 M(-32.9%) | -$6.82 M(+9.2%) | -$27.49 M(-3.9%) |
| Sep 2020 | - | -$6.25 M(-8.2%) | -$28.61 M(-15.4%) |
| Jun 2020 | - | -$6.81 M(-10.7%) | -$33.82 M(-9.6%) |
| Mar 2020 | - | -$7.62 M(-4.0%) | -$37.42 M(-8.6%) |
| Dec 2019 | -$40.96 M | -$7.94 M(-30.7%) | -$40.96 M(-12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$11.46 M(+10.1%) | -$46.62 M(-1.4%) |
| Jun 2019 | - | -$10.40 M(-6.8%) | -$47.28 M(-4.1%) |
| Mar 2019 | - | -$11.16 M(-17.9%) | -$49.33 M(-4.5%) |
| Dec 2018 | -$51.66 M(-4.2%) | -$13.59 M(+12.1%) | -$51.66 M(-5.9%) |
| Sep 2018 | - | -$12.13 M(-2.5%) | -$54.89 M(+3.3%) |
| Jun 2018 | - | -$12.44 M(-7.8%) | -$53.11 M(-4.0%) |
| Mar 2018 | - | -$13.50 M(-19.7%) | -$55.32 M(+2.5%) |
| Dec 2017 | -$53.95 M(-20.4%) | -$16.82 M(+62.6%) | -$53.95 M(-0.1%) |
| Sep 2017 | - | -$10.35 M(-29.4%) | -$53.99 M(-14.5%) |
| Jun 2017 | - | -$14.65 M(+20.8%) | -$63.16 M(+2.9%) |
| Mar 2017 | - | -$12.13 M(-28.1%) | -$61.35 M(-1.4%) |
| Dec 2016 | -$67.76 M(+10.9%) | -$16.87 M(-13.6%) | -$62.20 M(-2.6%) |
| Sep 2016 | - | -$19.51 M(+51.9%) | -$63.84 M(+11.0%) |
| Jun 2016 | - | -$12.85 M(-1.0%) | -$57.51 M(-8.7%) |
| Mar 2016 | - | -$12.98 M(-29.8%) | -$62.98 M(+3.1%) |
| Dec 2015 | -$61.10 M(+18.7%) | -$18.50 M(+40.3%) | -$61.10 M(+43.4%) |
| Sep 2015 | - | -$13.19 M(-28.0%) | -$42.60 M(+44.8%) |
| Jun 2015 | - | -$18.31 M(+64.9%) | -$29.41 M(+164.9%) |
| Mar 2015 | - | -$11.10 M | -$11.10 M |
| Dec 2014 | -$51.49 M(-3.5%) | - | - |
| Dec 2013 | -$53.35 M | - | - |
FAQ
- What is Aptevo Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual EBIT year-on-year change?
- What is Aptevo Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly EBIT year-on-year change?
- What is Aptevo Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM EBIT year-on-year change?
What is Aptevo Therapeutics annual earnings before interest & taxes?
The current annual EBIT of APVO is -$28.88 M
What is the all time high annual EBIT for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual earnings before interest & taxes is -$21.40 M
What is Aptevo Therapeutics annual EBIT year-on-year change?
Over the past year, APVO annual earnings before interest & taxes has changed by -$237.00 K (-0.83%)
What is Aptevo Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of APVO is -$5.21 M
What is the all time high quarterly EBIT for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly earnings before interest & taxes is -$4.04 M
What is Aptevo Therapeutics quarterly EBIT year-on-year change?
Over the past year, APVO quarterly earnings before interest & taxes has changed by +$1.17 M (+18.34%)
What is Aptevo Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of APVO is -$24.60 M
What is the all time high TTM EBIT for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM earnings before interest & taxes is -$11.10 M
What is Aptevo Therapeutics TTM EBIT year-on-year change?
Over the past year, APVO TTM earnings before interest & taxes has changed by +$4.28 M (+14.80%)